A new method for intravital assessment of functional activity of anticancer drug efflux membrane transporters in solid tumor srecimens

Antibiotiki i Khimioterapiya

Volumn 44, Issue 2, 1999, Pages 19-24

  Bogush, T A ^a   Smirnova, G B ^a   Bogush, E A ^a   Rober, J ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

Doxorubicin; New method for assessment of cytostatic efflux transporter functional activity; Solid tumors

Indexed keywords

ABC TRANSPORTER; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; ENZYME INHIBITOR; GLYCOPROTEIN P; SODIUM AZIDE; VERAPAMIL;

ADENOCARCINOMA; ANIMAL; ARTICLE; BREAST TUMOR; CELL CULTURE; CELL MEMBRANE; DRUG ANTAGONISM; DRUG EFFECT; EHRLICH ASCITES TUMOR; FEMALE; HUMAN; METABOLISM; MOUSE; SPECTROFLUOROMETRY; TRANSPORT AT THE CELLULAR LEVEL;

ADENOCARCINOMA; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; CARCINOMA, EHRLICH TUMOR; CELL MEMBRANE; DOXORUBICIN; ENZYME INHIBITORS; FEMALE; HUMANS; MICE; P-GLYCOPROTEIN; SODIUM AZIDE; SPECTROMETRY, FLUORESCENCE; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0032604948     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Germann U.A. Eur J Cancer 1996; 32A: 6: 927-944.
2. Cole S.P.C., Bhardawaj G., Gerlach J.H. et al. Science 1992; 258: 1650-1654.
3. Sugawara I. Cancer J 1995; 8: 2: 59-61.
4. Loe D.W., Deeley R.G., Cole S.P.C. Eur J Cancer 1996; 32A: 6: 945-957.
5. Izquierdo M.A., Scheffer G.L., Flens M.J. et al. Eur J Cancer Ibid: 979-984.
6. Childs S., Ling V. Important advances in oncology./ De Vita V.T., Hellman S., Rosenberg S.A., eds. Lippincott: Philadelphia 1994; 21-36.
7. Arceci R.J. Blood 1993; 81: 2215-2222.
8. Baldini N., Scotlandi K., Barbanti-Brodano G. et al. N Engl J Med 1995; 333: 1380-1385.
9. Leighton J.C., Goldstein L.J. Hematol Oncol Clin North Am 1995; 9: 251-274.
10. Marie J.P. Hematol Oncol Clin North Am Ibid: 239-250.
11. Pinedo H.M., Giaccone G.N. Engl J Med 1995; 333: 1417-1419.
12. Linn S.C., Giaccone G., van Diest P.J. et al. Ann Oncology 1995; 6: 679-685.
13. Broxterman H.J., Feller N., Kuiper C.M. et al. Int J Cancer 1995; 61: 880-886.
14. Feller N., Kuiper C.M., Lankelma J. et al. Br J Cancer 1995; 72: 543-549.
15. Broxterman H.J., Lankelma J., Pinedo H.M. Eur J Cancer 1996; 32A: 6: 1024-1033.
16. Bogush T., Smirnova G., Shubina I. et al. Cancer Chemother Pharmacol 1995; 35: 501-505.
17. Bogush T., Robert J. Anticancer Res 1996; 16: 365-368.
18. Fisher G.A., Lum B.L., Hausdorff J. et al. Eur J Cancer 1996; 32A: 6: 1082-1088.
19. Hedley D. W., Xiu-Yan Xie S., Minden M.D. et al. Leukaemia 1997; 11: 48-53.